All managers
Torray Investment Partners In Q2 2026, Torray Investment Partners held 88 US-listed stocks worth $741m. Its biggest move was adding to Alphabet (894% more shares, now 5.7%), followed by buying Accenture (now 2.8% of the portfolio). It started 5 new positions and sold out of 3. Its largest holding is Alphabet at 5.7%.
Source: SEC Form 13F for Q2 2026, filed 30 Jul 2026. How we use them
Latest 13F
Q2 2026
Filed 30 Jul 2026
US holdings
$741m
88 companies
See holdings
Q3 2026 13F due
24 days
Expected Mon 2 Nov
Want to know when Torray Investment Partners next files? Get a free email alert .
Holdings What changed Over time Look-through Sectors Value over time
What changed in Q2 2026 Against Q1 2026, by number of shares and adjusted for splits. Up to five of each, largest first; the full list is below.
US holdings from the 13F Q2 2026, filed 30 Jul 2026 (filing ): 5 new, 33 added to, 32 trimmed, 3 sold out. Select a row to see it over time. How this works Changes compare share counts with Q1 2026, adjusted for stock splits. Share classes of the same company are combined. Values are at quarter-end prices.
13F holdings with change from the previous quarter Company Value Shares Portfolio Change Q1 2026 Alphabet GOOG $42.1m 520,641 5.7%$42.1m ▲ Added +894%2.2% Broadcom AVGO $38.3m 101,468 5.2%$38.3m ▲ Added +2.0%4.5% Royalty Pharma RPRX $33.8m 602,028 4.5%$33.8m ▼ Trimmed -6.7%4.5% Constellation Energy CEG $26.8m 107,742 3.6%$26.8m ▲ Added +17%3.8% CNA Financial CNA $25.4m 522,241 3.4%$25.4m ▲ Added +11%3.2% KKR & Co. KKR $22.9m 573,623 3.1%$22.9m ▲ Added +19%2.8% Chevron CVX $22.4m 135,300 3.0%$22.4m ▲ Added +0.2%4.1% Blackstone BX $22.2m 188,812 3.0%$22.2m ▲ Added +14%2.8% Amgen AMGN $21.6m 59,771 2.9%$21.6m ▲ Added +11%2.8% Comcast CMCSA $21.2m 863,372 2.9%$21.2m ▲ Added +56%2.3% Hewlett Packard Enterprise C HPE $21.2m 183,153 2.9%$21.2m ▼ Trimmed -51%3.5% Accenture ACN $20.9m 167,690 2.8%$20.9m ▲ New– NextEra Energy NEE $20.9m 237,562 2.8%$20.9m ▲ Added +19%2.7% Abbvie ABBV $20.8m 82,602 2.8%$20.8m ▼ Trimmed -12%3.0% ONEOK OKE $20.8m 238,831 2.8%$20.8m ▲ Added +0.1%3.2% Pfizer PFE $20.7m 859,418 2.8%$20.7m ▲ Added +11%3.2% Phillips 66 PSX $19.9m 117,795 2.7%$19.9m ▼ Trimmed -16%3.8% PepsiCo PEP $19.8m 146,268 2.7%$19.8m ▲ Added +7.6%3.1% Texas Instruments TXN $19.6m 65,895 2.6%$19.6m ▼ Trimmed -46%3.5% Prologis PLD $18.2m 134,084 2.5%$18.2m ▲ Added +0.5%2.6% Amazon.com AMZN $16.2m 68,062 2.2%$16.2m ▼ Trimmed -5.2%2.2% Bloom Energy BE $15.9m 52,565 2.1%$15.9m ▼ Trimmed -12%1.2% Marsh MRSH $15.4m 92,694 2.1%$15.4m ▼ Trimmed -1.7%2.4% Apple AAPL $14.0m 48,366 1.9%$14.0m ▼ Trimmed -2.4%1.9% Microsoft MSFT $13.5m 36,160 1.8%$13.5m ▼ Trimmed -53%4.2% Casey’s General Stores CASY $13.3m 16,784 1.8%$13.3m ▼ Trimmed -2.0%1.8% Taiwan Semiconductor Manufacturing TSM $12.6m 26,309 1.7%$12.6m ▼ Trimmed -3.0%1.3% KLA KLAC $11.1m 36,890 1.5%$11.1m ▼ Trimmed -16%0.9% Amphenol APH $10.4m 59,235 1.4%$10.4m ▼ Trimmed -6.2%1.2% Tradeweb Markets TW $7.6m 75,987 1.0%$7.6m ▼ Trimmed -0.1%1.3% Vertex Pharmaceuticals VRTX $7.6m 15,215 1.0%$7.6m ▼ Trimmed -1.1%1.0% Visa V $7.6m 22,017 1.0%$7.6m ▲ Added +11%0.9% Lonza Group LZAGY $6.2m 91,339 0.8%$6.2m ▼ Trimmed -1.2%0.9% Arthur J Gallagher & Co AJG $6.0m 26,276 0.8%$6.0m ▼ Trimmed -9.5%0.9% RBC Bearings RBC $5.9m 9,112 0.8%$5.9m ▲ Added +0.4%0.7% O'Reilly Automotive ORLY $5.6m 60,821 0.8%$5.6m ▼ Trimmed -2.5%0.8% Monolithic Power Systems MPWR $5.1m 3,715 0.7%$5.1m ▲ Added +0.2%0.6% ServiceNow NOW $5.1m 51,543 0.7%$5.1m ▼ Trimmed -6.0%0.8% Krystal Biotech KRYS $4.5m 12,156 0.6%$4.5m ▲ Added +1.0%0.5% BioMarin Pharmaceutical BMRN $4.4m 77,705 0.6%$4.4m ▼ Trimmed -0.6%0.7% Veeva Systems VEEV $4.4m 24,625 0.6%$4.4m ▲ Added +3.6%0.6% Verisk Analytics VRSK $4.4m 24,309 0.6%$4.4m ▼ Trimmed -0.3%0.7% Sherwin Williams SHW $4.2m 12,175 0.6%$4.2m ▲ Added +4.8%0.6% GE Aerospace GE $4.1m 10,999 0.6%$4.1m ▲ Added +4.4%0.4% Axsome Therapeutics AXSM $3.7m 14,928 0.5%$3.7m ▲ Added +1.0%0.4% Fabrinet FN $3.4m 5,994 0.5%$3.4m ▼ Trimmed -15%0.5% Entegris ENTG $3.2m 18,001 0.4%$3.2m ▲ Added +0.3%0.3% Halozyme Therapeutics HALO $3.0m 38,703 0.4%$3.0m ▲ Added +1.4%0.4% Ryan Specialty Holdings RYAN $2.9m 77,911 0.4%$2.9m ▲ Added +15%0.3% Syndax Pharmaceuticals SNDX $2.9m 133,835 0.4%$2.9m ▲ Added +28%0.4% Dynatrace DT $2.9m 66,492 0.4%$2.9m ▼ Trimmed -5.0%0.4% Natera NTRA $2.6m 9,730 0.4%$2.6m ▲ Added +1.7%0.3% BWX Technologies BWXT $2.5m 12,633 0.3%$2.5m ▲ Added +0.6%0.4% Evolv Technologies EVLV $2.3m 392,714 0.3%$2.3m ▲ Added +11%0.3% Zoom Communications ZM $2.1m 24,796 0.3%$2.1m ▲ New– Mettler-Toledo International MTD $2.1m 1,671 0.3%$2.1m ▼ Trimmed -0.4%0.3% FTI Consulting FCN $2.0m 13,500 0.3%$2.0m ▲ Added +4.4%0.3% Verastem VSTM $1.8m 477,455 0.3%$1.8m ▲ Added +60%0.2% Novanta NOVT $1.8m 11,141 0.2%$1.8m ▲ New– Jack Henry & Associates JKHY $1.8m 12,856 0.2%$1.8m ▼ Trimmed -12%0.3% Cooper Companies COO $1.7m 23,286 0.2%$1.7m ▼ Trimmed -8.4%0.3% Berkshire Hathaway BRK.B $1.4m 2,884 0.2%$1.4m 0.2% Johnson & Johnson JNJ $1.1m 4,141 0.1%$1.1m 0.1% JPMorgan Chase JPM $969k 2,959 0.1%$969k ▼ Trimmed -92%1.7% Home Depot HD $876k 2,485 0.1%$876k ▼ Trimmed -22%0.1% United Rentals URI $748k 660 0.1%$748k 0.1% Vanguard Index Fds VOO $673k 5,361 0.1%$673k ▲ Added +108%0.1% American Express AXP $665k 1,965 0.1%$665k 0.1% NVIDIA NVDA $588k 2,938 0.1%$588k ▼ Trimmed -3.8%0.1% Costco Wholesale COST $587k 628 0.1%$587k 0.1% Tesla TSLA $526k 1,250 0.1%$526k 0.1% Morgan Stanley MS $497k 2,377 0.1%$497k ▼ Trimmed -92%0.7% Rolls Royce Holdings RYCEY $481k 25,000 0.1%$481k 0.1% Eli Lilly & Co LLY $477k 398 0.1%$477k 0.1% Rocket Lab 25718GBP $457k 4,500 0.1%$457k ▼ Trimmed -50%0.1% Northrop Grumman NOC $452k 887 0.1%$452k 0.1% Enbridge ENB $450k 8,310 0.1%$450k 0.1% Danaher DHR $356k 1,871 0.1%$356k 0.1% 3M Company MMM $324k 2,000 0.0%$324k 0.0% RTX RTX $320k 1,689 0.0%$320k 0.1% UnitedHealth Group UNH $284k 683 0.0%$284k ▲ New– Edwards Lifesciences EW $271k 2,994 0.0%$271k 0.0% Schlumberger SLB $264k 5,681 0.0%$264k 0.0% Wells Fargo & Company WFC $248k 3,000 0.0%$248k 0.0% Ishares Tr EFA $245k 1,972 0.0%$245k ▲ Added +42%0.1% Motorola Solutions MSI $235k 566 0.0%$235k 0.0% Union Pacific UNP $231k 850 0.0%$231k 0.0% BNY BK $229k 1,584 0.0%$229k ▲ New– Huron Consulting Group HURN – – – ▼ Sold out0.3% Qualys QLYS – – – ▼ Sold out0.2% Honeywell HON – – – ▼ Sold out0.0%
Show all 91 Download the Q2 2026 holdings: CSV · JSON · Markdown
How the portfolio has changed Each bar is one 13F. Select a bar or press play to see that quarter’s 12 largest positions. How this works Bars are split by share of the US portfolio: the six biggest holdings over the period in colour, everything else in grey. The last eight quarters are shown in full, earlier years at year end.
2013 · Everything else: 100.0% 2014 · Fiserv: 3.0% 2014 · Everything else: 97.0% 2015 · Alphabet: 4.1% 2015 · Fiserv: 3.5% 2015 · Everything else: 92.3% 2016 · Alphabet: 2.9% 2016 · Fiserv: 2.4% 2016 · Everything else: 94.8% 2017 · Alphabet: 3.0% 2017 · Fiserv: 2.2% 2017 · Everything else: 94.8% 2018 · Fiserv: 2.4% 2018 · Everything else: 97.6% 2019 · Berkshire Hathaway: 2.7% 2019 · Everything else: 97.3% 2020 · Berkshire Hathaway: 3.0% 2020 · Everything else: 97.0% 2021 · Alphabet: 3.5% 2021 · Fiserv: 3.1% 2021 · Berkshire Hathaway: 3.4% 2021 · Everything else: 90.1% 2022 · Alphabet: 3.1% 2022 · Fiserv: 2.8% 2022 · Berkshire Hathaway: 3.6% 2022 · Phillips 66: 2.3% 2022 · Everything else: 88.2% 2023 · Alphabet: 4.3% 2023 · Fiserv: 3.3% 2023 · Berkshire Hathaway: 3.7% 2023 · Phillips 66: 3.0% 2023 · Everything else: 85.8% Q3 ’24 · Alphabet: 4.3% Q3 ’24 · Fiserv: 3.8% Q3 ’24 · Royalty Pharma: 3.4% Q3 ’24 · Berkshire Hathaway: 3.7% Q3 ’24 · Everything else: 84.8% Q4 ’24 · Alphabet: 4.8% Q4 ’24 · Fiserv: 3.7% Q4 ’24 · Royalty Pharma: 2.5% Q4 ’24 · Berkshire Hathaway: 3.1% Q4 ’24 · Broadcom: 2.7% Q4 ’24 · Everything else: 83.2% Q1 ’25 · Alphabet: 3.4% Q1 ’25 · Fiserv: 3.9% Q1 ’25 · Royalty Pharma: 4.0% Q1 ’25 · Berkshire Hathaway: 3.3% Q1 ’25 · Phillips 66: 2.5% Q1 ’25 · Everything else: 82.9% Q2 ’25 · Royalty Pharma: 3.6% Q2 ’25 · Berkshire Hathaway: 2.6% Q2 ’25 · Broadcom: 6.0% Q2 ’25 · Phillips 66: 3.5% Q2 ’25 · Everything else: 84.3% Q3 ’25 · Royalty Pharma: 3.4% Q3 ’25 · Broadcom: 4.2% Q3 ’25 · Phillips 66: 3.9% Q3 ’25 · Everything else: 88.6% Q4 ’25 · Royalty Pharma: 4.1% Q4 ’25 · Broadcom: 4.5% Q4 ’25 · Phillips 66: 3.8% Q4 ’25 · Everything else: 87.5% Q1 ’26 · Royalty Pharma: 4.5% Q1 ’26 · Broadcom: 4.5% Q1 ’26 · Phillips 66: 3.8% Q1 ’26 · Everything else: 87.2% Q2 ’26 · Alphabet: 5.7% Q2 ’26 · Royalty Pharma: 4.5% Q2 ’26 · Broadcom: 5.2% Q2 ’26 · Everything else: 84.6% 2013
2015
2017
2019
2021
2023
Q4 ’24
Q2 ’25
Q4 ’25
Q2 ’26
2013: Alphabet 0.0%, Fiserv 0.0%, Royalty Pharma 0.0%, Berkshire Hathaway 0.0%, Broadcom 0.0%, Phillips 66 0.0%; 2014: Alphabet 0.0%, Fiserv 3.0%, Royalty Pharma 0.0%, Berkshire Hathaway 0.0%, Broadcom 0.0%, Phillips 66 0.0%; 2015: Alphabet 4.1%, Fiserv 3.5%, Royalty Pharma 0.0%, Berkshire Hathaway 0.0%, Broadcom 0.0%, Phillips 66 0.0%; 2016: Alphabet 2.9%, Fiserv 2.4%, Royalty Pharma 0.0%, Berkshire Hathaway 0.0%, Broadcom 0.0%, Phillips 66 0.0%; 2017: Alphabet 3.0%, Fiserv 2.2%, Royalty Pharma 0.0%, Berkshire Hathaway 0.0%, Broadcom 0.0%, Phillips 66 0.0%; 2018: Alphabet 0.0%, Fiserv 2.4%, Royalty Pharma 0.0%, Berkshire Hathaway 0.0%, Broadcom 0.0%, Phillips 66 0.0%; 2019: Alphabet 0.0%, Fiserv 0.0%, Royalty Pharma 0.0%, Berkshire Hathaway 2.7%, Broadcom 0.0%, Phillips 66 0.0%; 2020: Alphabet 0.0%, Fiserv 0.0%, Royalty Pharma 0.0%, Berkshire Hathaway 3.0%, Broadcom 0.0%, Phillips 66 0.0%; 2021: Alphabet 3.5%, Fiserv 3.1%, Royalty Pharma 0.0%, Berkshire Hathaway 3.4%, Broadcom 0.0%, Phillips 66 0.0%; 2022: Alphabet 3.1%, Fiserv 2.8%, Royalty Pharma 0.0%, Berkshire Hathaway 3.6%, Broadcom 0.0%, Phillips 66 2.3%; 2023: Alphabet 4.3%, Fiserv 3.3%, Royalty Pharma 0.0%, Berkshire Hathaway 3.7%, Broadcom 0.0%, Phillips 66 3.0%; Q3 ’24: Alphabet 4.3%, Fiserv 3.8%, Royalty Pharma 3.4%, Berkshire Hathaway 3.7%, Broadcom 0.0%, Phillips 66 0.0%; Q4 ’24: Alphabet 4.8%, Fiserv 3.7%, Royalty Pharma 2.5%, Berkshire Hathaway 3.1%, Broadcom 2.7%, Phillips 66 0.0%; Q1 ’25: Alphabet 3.4%, Fiserv 3.9%, Royalty Pharma 4.0%, Berkshire Hathaway 3.3%, Broadcom 0.0%, Phillips 66 2.5%; Q2 ’25: Alphabet 0.0%, Fiserv 0.0%, Royalty Pharma 3.6%, Berkshire Hathaway 2.6%, Broadcom 6.0%, Phillips 66 3.5%; Q3 ’25: Alphabet 0.0%, Fiserv 0.0%, Royalty Pharma 3.4%, Berkshire Hathaway 0.0%, Broadcom 4.2%, Phillips 66 3.9%; Q4 ’25: Alphabet 0.0%, Fiserv 0.0%, Royalty Pharma 4.1%, Berkshire Hathaway 0.0%, Broadcom 4.5%, Phillips 66 3.8%; Q1 ’26: Alphabet 0.0%, Fiserv 0.0%, Royalty Pharma 4.5%, Berkshire Hathaway 0.0%, Broadcom 4.5%, Phillips 66 3.8%; Q2 ’26: Alphabet 5.7%, Fiserv 0.0%, Royalty Pharma 4.5%, Berkshire Hathaway 0.0%, Broadcom 5.2%, Phillips 66 0.0% ▶ Play Q2 2026
Alphabet 5.7% Broadcom 5.2% Royalty Pharma 4.5% Constellation Energy 3.6% CNA Financial 3.4% KKR & Co. 3.1% Chevron 3.0% Blackstone 3.0% Amgen 2.9% Comcast 2.9% Hewlett Packard Enterprise C 2.9% Accenture 2.8% Q4 2013 Q2 2026
Look-through earnings Torray Investment Partners’s share of the profits of the US companies it holds. How this works Look-through earnings, Q2 2026
$36.3m
Last 12 months, holdings with SEC financials
Price paid for those earnings
18.3×
Value of those holdings ÷ their earnings
Earnings per share growth
+23.8%
Same holdings, against a year earlier
Portfolio covered
90%
Of the 13F value
By year Rolling 12 months
Q1 2017: $7.2m Q2 2017: $8.0m Q3 2017: $6.5m Q4 2017: $546k Q1 2018: $7.7m Q2 2018: $9.9m Q3 2018: $6.8m Q4 2018: $8.0m Q1 2019: $9.4m Q2 2019: $10.5m Q3 2019: $7.4m Q4 2019: $5.2m Q1 2020: $3.6m Q3 2020: $5.2m Q4 2020: $6.0m Q1 2021: $8.6m Q2 2021: $7.2m Q3 2021: $5.6m Q4 2021: $6.5m Q1 2022: $5.3m Q2 2022: $5.8m Q3 2022: $7.5m Q4 2022: $7.5m Q1 2023: $6.9m Q2 2023: $7.2m Q3 2023: $8.1m Q4 2023: $7.0m Q1 2024: $6.0m Q2 2024: $6.4m Q3 2024: $7.0m Q4 2024: $6.9m Q1 2025: $6.3m Q2 2025: $6.2m Q3 2025: $7.0m Q4 2025: $5.8m Q1 2026: $5.7m Q2 2026: $12.8m $22.3m 2017
$32.4m 2018
$32.5m 2019
$11.7m 2020
$27.9m 2021
$26.1m 2022
$29.2m 2023
$26.3m 2024
$25.2m 2025
$18.5m 2026*
2017: $22.3m; 2018: $32.4m; 2019: $32.5m; 2020: $11.7m; 2021: $27.9m; 2022: $26.1m; 2023: $29.2m; 2024: $26.3m; 2025: $25.2m; 2026 (2 quarters): $18.5m
Holdings behind Q2 2026 (latest) Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021
Show all 30 Net income is as reported (GAAP), so it includes one-off items and, for some companies, gains or losses on investments they hold. Companies that report under IFRS (most non-US companies) or whose shares we can’t match reliably are left out; “portfolio covered” shows how much is included. Look-through earnings explained . Growth compares earnings per share over the last 12 months with the 12 months a year earlier, for holdings profitable in both.
US holdings by sector Technology 26.5% Health care 17.7% Financials 10.9% Communication and media 8.5% Insurance 6.9% Utilities 6.4% Energy 5.8% Consumer discretionary 5.6% Industrials 4.7% Consumer staples 2.7% Other 0.4% Not classified 3.9% Sectors are grouped from each company’s SEC industry code, as a share of the Q2 2026 13F.
US portfolio value by quarter $567m Q3 ’23
$618m Q4 ’23
$668m Q1 ’24
$669m Q2 ’24
$715m Q3 ’24
$697m Q4 ’24
$671m Q1 ’25
$689m Q2 ’25
$737m Q3 ’25
$698m Q4 ’25
$682m Q1 ’26
$741m Q2 ’26
Q3 ’23: $567m; Q4 ’23: $618m; Q1 ’24: $668m; Q2 ’24: $669m; Q3 ’24: $715m; Q4 ’24: $697m; Q1 ’25: $671m; Q2 ’25: $689m; Q3 ’25: $737m; Q4 ’25: $698m; Q1 ’26: $682m; Q2 ’26: $741m From each quarter’s 13F. Changes reflect both trading and share-price moves.